According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a “ga...
SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...
For reasons not yet fully understood, beginning in 2022 the world experienced an unprecedented surge in cholera outbreak...
South Korea-based International Vaccine Institute (IVI) has sigend a Memorandum of Understanding (MoU) with Nankai ...
Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (S...
TechInvention Lifecare in India, has partnered with Eubiologics Co. in South Korea, to launch Euv...
Jean-Yves Duclos, Minister of Health, and Harjit S. Sajjan, Minister of International Development and Minister responsib...
The International Vaccine Institute (IVI), based in South Korea, has begun clinical development of DuoChol, a new low-co...
American pharmaceutical firm Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has approved PREVN...
The results from a new YouGov survey called, ‘What’s Next for COVID-19 in Singapore?’, commissioned by...
Many disease-causing bacteria like Streptococcus pneumoniae (S. pneumoniae) are encased in a sugar layer called the caps...
Beijing Minhai Biotechnology Co., (BioMinhai), a wholly-owned subsidiary of China-based Shenzhen Kangtai Biological Prod...
Sanofi and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic ...
DXVX has announced that its affiliated company Oxford Vacmedix (OVM) has completed Phase 1a trial of cancer vaccine and ...
Australian biotech firm CSL recently celebrated the official opening of the company's new state-of-the-art research and ...
Victoria University of Wellington and University of Auckland, in New Zealand (NZ) have been named as co-hosts of a ...
American pharmaceutical firm Pfizer has announced that the Singapore Health Sciences Authority (HSA) has approved its 20...
Likang Life Sciences has received National Medical Products Administration (NMPA) approval for the clinical trial of its...